about
Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma.High Expression of Retinoblastoma-Binding Protein 2 (RBP2) in Patients with Hepatocellular Carcinoma and Its Prognostic Significance.Diagnostic and prognostic roles of IRAK1 in hepatocellular carcinoma tissues: an analysis of immunohistochemistry and RNA-sequencing data from the cancer genome atlasA comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma.Sorafenib: A Review in Hepatocellular Carcinoma.Metabolomics and eicosanoid analysis identified serum biomarkers for distinguishing hepatocellular carcinoma from hepatitis B virus-related cirrhosis.Efficacy of anti-VEGF agents in the treatment of elderly hepatocellular carcinoma: a systematic review.Dose age affect the efficacy of molecular targeted agents in the treatment of hepatocellular carcinoma: a systematic review and meta-analysis.Deep Learning based multi-omics integration robustly predicts survival in liver cancer.Target-specific delivery of siRNA into hepatoma cells' cytoplasm by bifunctional carrier peptide.Paclitaxel-loaded nanoparticles decorated with bivalent fragment HAb18 F(ab')2 and cell penetrating peptide for improved therapeutic effect on hepatocellular carcinoma.Enhanced antitumor activity of combined megestrol acetate and arsenic trioxide treatment in liver cancer cells.Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy.Integrated multi-omics data analysis identifying novel drug sensitivity-associated molecular targets of hepatocellular carcinoma cells.CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial.
P2860
Q33740486-CC33ABDF-0CFE-4DCF-8E50-5DF0A4672DCBQ33792639-164C374F-FDF5-42E2-8C80-7F8E768894D6Q36327564-D5477AFF-9E46-4F8C-829B-EABF1A994174Q38430715-6AA071DE-6CFC-4A48-A695-9088C1B83EAEQ39181337-6DD08D6F-601C-47BB-8F0D-91092F9111FFQ41926352-16410EDC-209D-4FA6-ABA1-8A17F0DE705CQ46024539-0A1BCF58-5776-4444-95A1-1FCAAB2981DBQ47102621-A0C7158D-55E7-45F7-B5B9-E23987BC9EC2Q47855807-D9995BFD-E45B-47CF-BA27-E94669DC2727Q51091545-A6625F79-3B92-4965-840D-ED6AAF2FE7C6Q51813743-9B753067-6E42-486B-A6DD-714303306A4CQ52629281-B34601C3-25E3-40E0-80E3-3EAB9092C317Q52722792-890A44AD-260F-4C7E-A862-437C1E290FA1Q55396493-FB7941DC-698F-4933-8DB0-EC72A3774EB0Q55477963-A8157983-5BDD-46A9-A458-BEA2DC5C6DC6
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Challenges of advanced hepatocellular carcinoma
@ast
Challenges of advanced hepatocellular carcinoma
@en
Challenges of advanced hepatocellular carcinoma
@nl
type
label
Challenges of advanced hepatocellular carcinoma
@ast
Challenges of advanced hepatocellular carcinoma
@en
Challenges of advanced hepatocellular carcinoma
@nl
prefLabel
Challenges of advanced hepatocellular carcinoma
@ast
Challenges of advanced hepatocellular carcinoma
@en
Challenges of advanced hepatocellular carcinoma
@nl
P2093
P2860
P50
P3181
P356
P1476
Challenges of advanced hepatocellular carcinoma
@en
P2093
Andrea L Inghilesi
Gian G Taliani
Sami Aburas
P2860
P304
P3181
P356
10.3748/WJG.V22.I34.7645
P407
P5008
P577
2016-09-01T00:00:00Z